TRPM3 and myalgic encephalomeyelitis/chronic fatigue syndrome: Our previous research has suggested that people suffering from post-COVID-19 condition also have TRPM3 dysfunction in NK cells (53), which is a biomarker consistently identified in ME/CFS patients (31, 48, 49).